Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease-Reference-Cited by-同舟云学术

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease

Published:2018 Issue:1 Volume:16 Page:75
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Hiraoka Sakiko¹,Takashima Shiho¹,Kondo Yoshitaka²,Inokuchi Toshihiro¹,Sugihara Yuusaku¹,Takahara Masahiro¹,Kawano Seiji¹,Harada Keita¹,Kato Jun³,Okada Hiroyuki¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

2. Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

3. Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

https://synapse.koreamed.org/pdf/10.5217/ir.2018.16.1.75

Reference20 articles.

1. Reliability of a Crohnʼs Disease Clinical Classification Scheme Based on Disease Behavior

2. Review article: recurrence of Crohn's disease after surgery – the need for treatment of new lesions

3. Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort